(Q53200598)

12 May 2018

title

Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component. (English)

1 reference

12 May 2018

author name string

Janciauskiene S

1

1 reference

12 May 2018

García de Frutos P

2

1 reference

12 May 2018

Carlemalm E

3

1 reference

12 May 2018

Dahlbäck B

4

1 reference

12 May 2018

Eriksson S

5

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 November 1995

1 reference

12 May 2018

Journal of Biological Chemistry

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 May 2018

volume

270

1 reference

12 May 2018

page(s)

26041-26044

1 reference

12 May 2018

issue

44

1 reference

12 May 2018

Structure of pentameric human serum amyloid P component

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Localization of amyloid P component in human brain: vascular staining patterns and association with Alzheimer's disease lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Calcium-dependent polymerization of human serum amyloid P component is inhibited by heparin and dextran sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

In vitro fibril formation from alpha 1-antitrypsin-derived C-terminal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Amyloid P component is located on elastic fibre microfibrils in normal human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

Structure, expression, and evolution of guinea pig serum amyloid P component and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.44.26041

21 January 2018

Identifiers

DOI

10.1074/JBC.270.44.26041

1 reference

12 May 2018

PubMed ID

7592799

1 reference

12 May 2018